Bortemed (Bortezomib)

Generic name

Bortezomib

Strength

3.5 mg

Dosage form

Powder for Injection(IV)

Prescription

Prescription only (Rx)

Used for

• Mantle Cell Lymphoma
• Multiple Myeloma

Indications

This medication is indicated for treating adults with progressive or previously untreated multiple myeloma. It also treats previously untreated mantle cell lymphoma in patients unsuitable for stem cell transplantation.

Dosage and administration

The recommended dose is 1.3 mg/m² given as a 3–5 second intravenous bolus. It is typically administered twice weekly for two weeks, followed by a ten-day rest period.

Prescription medicine, supplied by Getmeds, an FDA Philippines-licensed distributor. Request a quotation.